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Uterine natural killer cells
a b s t r a c t
Identification of biomarkers of optimal uterine receptivity to the implanting embryo as
well as biomarkers of oocyte competence would undoubtedly improve the efficiency of
assisted reproductive technology (ART). Expression of IL-15 and IL-18 has been shown to
bedifferent inpatientswith failed implantationafter IVF/ICSI comparedwith fertile controls
and both correlate with local uNK (CD56+) recruitment and angiogenesis. Tumor necrosis
factor weak inducer of apoptosis (TWEAK) has been described in mice as a potent early
immune regulator able to protect the conceptus. The results of our studies inhuman suggest
that TWEAK modulates the IL-18 related cytotoxicity of uNK cells. Quantification of IL-18,
TWEAKand IL-15mRNAexpressionby real-timePCR inendometrial tissue collected inmid-
luteal phase of non-conception cycles allowed documentation of physiological events that
occur at the time of uterine receptivity. Such information may be useful for the physician
especially in patients where embryos fail to implant. Cytokine quantification may assist
in understanding the mechanisms leading to repeated IVF/ICSI failure: either depletion of
cytokines necessary for the apposition-adhesion, or an excess of cytokines leading to local
cytotoxicity, may impair the implantation of the embryo. Other new data suggest that a
pre-conception dialogue mediated by the oocyte and the follicular fluid and the oocyte
may contribute to later implantation success. Follicular concentration of G-CSF appears
as a useful biomarker of oocyte competence before fertilization. Moreover both in human
and animal models, evidence of a role of the endometrium as a biosensor of the embryo is
emerging.
© 2011 Elsevier Ireland Ltd. All rights reserved.
1. Introduction
In the clinic, less than 5% of oocytes collected and only
20–25% of embryos transferred lead to a birth (Patrizio
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and Sakkas, 2009). Optimisation of embryo competence
as well as corresponding uterine receptivity is an absolute
requirement to improve success in reproductive medicine.
Such objectives rely on a better understanding of the pre-
and peri-conception dialogue. The success of implantation
depends on a receptive endometrium, a normal blasto-
cyst and synchronized cross-talk at the maternal–fetal
interface. A cascade of cytokines, chemokines and growth
factors mediate this dialogue before fertilization of the
oocyte and before implantation in the endometrium
(Guzeloglu-Kayisli et al., 2009; Red-Horse et al., 2004;
0165-0378/$ – see front matter © 2011 Elsevier Ireland Ltd. All rights reserved.
doi:10.1016/j.jri.2011.01.007
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Salamonsen et al., 2007; van Mourik et al., 2009). To
achieve the fertilization step, a good quality oocyte must
meet a normal sperm with low DNA damage, leading
to the development of a functionally normal blastocyst
able to communicate with thematernal endometrium. The
progression of pregnancy then requires immunological tol-
erance which allows conceptus survival. Such cross-talk
involving both the immune and endocrine systems is cru-
cial to prevent implantation failure. A better knowledge
of the uterine–oocyte/embryo interaction and regulation
of both the “seed and soil” during endometrial implan-
tation is mandatory to increase the efficacy of assisted
reproduction technology. Adequate coordination between
embryo and mother is indeed crucial. In this short review,
we will focus exclusively on some specific cytokines –
interleukin-18 (IL-18), IL-15 and tumor necrosis factor
weak inducer of apoptosis (TWEAK) in the endometrium
and granulocyte colony-stimulating factor (G-CSF, CSF3) in
the follicularfluid– since theyappear aspotential biomark-
ers to document the local pre-conception environment and
its equilibrium. Such immune biomarkersmay be clinically
useful for understanding mechanisms of implantation fail-
ure after embryo transfer.
2. Endometrial uterine receptivity: vascular
remodeling and the underlying abnormal cytokine
network
It has been proposed that uterine natural killer (uNK)
cells can exert, directly or indirectly, both positive and
negative control over the early events of implantation
(Leonard et al., 2006; van den Heuvel et al., 2005). These
cells secrete an array of cytokines important for adequate
local immune regulation, angiogenesis, placental develop-
ment, and establishment of pregnancy (Zhang et al., 2010).
Implantation failure, recurrentmiscarriageandpreeclamp-
sia have several recognized causes in common, but inmost
cases the precise etiology remains obscure. Various studies
have identified the importance of the local immune envi-
ronment and indicate the need to develop clinical tools
to explore these endometrial dysregulations (Kwak-Kim
and Gilman-Sachs, 2008; Quenby and Farquharson, 2006;
Tuckerman et al., 2010).
Indeed the semantic distinction between implantation
failure, abortion and preeclampsia might in fact be more
quantitative than qualitative (Chaouat, 2008). Dysregula-
tion of events occurring immediately after or even before
conception is important determinants of embryo fate and
pregnancy success. An important subset of implantation
defects/early abortion cases is the consequence of a dereg-
ulation of the interleukin, tumor necrosis factor (TNF!)
and interferon systems, as well as networks controlled and
mediated by uNK cells. Both deficient and excess expres-
sion of cytokines, as well as immune cell numbers and
activation phenotype, play key roles in implantation, since
these actors can have both positive and negative effects.
In our laboratory, we observed in human and mice that
a proper balance in the IL-12, IL-18 and IL-15 and a correct
NK activation state result in implantation and success-
ful pregnancy. Conversely, imbalances in these parameters
correlate with implantation failure or early pregnancy
loss (Ledee-Bataille et al., 2005). Their expression controls
the local recruitment of CD56+ uNK cells and associated
sub-endometrial angiogenesis, as reflected by the endome-
trial vascular flow index determined by three-dimensional
ultrasound (Ledee et al., 2008a,b). Such expressionpatterns
are reproducible from one cycle to another for the same
patient, and are strongly down-regulated by high concen-
trations of oestrogen (Ledee et al., 2006). The excellent
correlation between IL-15 mRNA expression and the sub-
endometrial vascular flow index suggests that this cytokine
and the uNK cells that produce it participate in the local
control of angiogenesis (Ledee et al., 2008a). Abnormal
sub-endometrial vascularisation assessed by ultrasound
may be the consequence of distinct cytokine dysregulation
patterns. These may cause implantation failure through
abnormal (insufficient or excessive) recruitment of uNK
cells or through inadequate endothelial vascular remod-
eling before implantation.
3-D ultrasonography with vocal analysis may inform
on uterine preparation for a constructive dialogue with
the conceptus, and ability to provide adequate embry-
otrophic factors and undergo angiogenesis. However in the
clinic, most ultrasonic assessments are performed either
at the beginning of the cycle to evaluate the ovarian
reserve or in late proliferative phase just before triggering
ovulation. Much more rarely, ultrasonic assessments are
performed in themid luteal phasewhich is clearly the only
phase relevant for this issue. Focusing on vascularisation
at the time of uterine receptivity to embryo implantation
is absolutely mandatory from a physiological point of view
(Ledee, 2005). Patients with low sub-endometrial vascular
flow index and low IL-15 mRNA are patients with insuf-
ficient uNK recruitment and/or inadequate uNK-derived
angiogenic-relatedproteins In contrast, somepatientswith
implantation failures exhibit very high endometrial vascu-
lar flow index and at the same time, high IL-15 and IL-18
mRNAs and CD56+ cell count. A type 1 immune response
could possibly be involved in such profile of implantation
failure (Kwak-Kim and Gilman-Sachs, 2008). The number
of uNK cells recruited at the time of implantation aswell as
their state of activation need to be explored in the clinic.
In daily clinical practice, ultrasonic evaluation of suben-
dometrial vascular flow index and measurement of the
IL-15 and IL-18 mRNAs together with CD56+ uNK cell
counts may thus be useful to identify those women at risk
of IVF/ICSI implantation failure.
3. The role of endometrial tumor necrosis
factor-like weak inducer of apoptosis (TWEAK)
The role of TWEAK appears very important in implanta-
tion. TWEAK is a type-2 transmembrane protein, member
of the TNF superfamily. This cytokine is described as act-
ing in a Yin and Yang relationship with TNF! (Bell, 2006),
because it counteracts its deleterious effects and has pro
angiogenic properties (Donohue et al., 2003). Although it
was first described as a weak apoptosis inducer, it triggers
multiple cellular responses through its receptor, the fibro-
blast growth factor inducible-14 (Fn-14). These responses
range from proliferation to cell death and stimulation of
angiogenesis. It is highly expressed by several types of
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immune cells (such as monocytes, dendritic cells, and
NK cells) and is expressed in many tissues, including the
endometrium. uNKcells expressing theNKp46 cytotoxicity
KIR receptor accumulate specifically in the endometriumof
patients with concomitant IL-18 over-expression and low
TWEAK expression. This suggests that TWEAK is involved
in the control of cytotoxicity in uNK cells (Petitbarat et al.,
2010).
TWEAK and its receptor Fn-14 localize in the endome-
trial glands and surface epithelium during the proliferative
and luteal phases. They also appear scattered within
the stroma, around spiral arteries, and in the luminal
epithelium.Nodifferences in immunostaining are detected
among the different phases of the cycle, suggesting that
TWEAK plays an early role in preventing local cytotoxic-
ity and may counterbalance the cytotoxic function of uNK
cells and favor theconstructiveangiogenic/immunotrophic
pathways. Recent studies in humans indicate that the
ratio of IL-15 and IL-18 to TWEAK mRNA expression are
more important than the normalised values of IL-15, IL-
18 or TWEAK mRNA alone (Petitbarat et al., 2010). This
testifies that the final balance of controlling signals to acti-
vation signals is likely more important than an apparently
objectivemeasure of the activation pathways. Indeed, only
patients with a high IL-18/TWEAK mRNA ratio quantified
by real time PCR show both excessive uNK cell recruit-
ment with simultaneous activation of NKp46, the main
endometrial activating receptor of uNK cells cytotoxicity
(Petitbarat et al., 2011). In contrast, patient showing low
endometrial IL-15/Fn-14 expression exhibit CD56+ uNK
cell depletion. Suchquantificationmay therefore behelpful
for revealing an imbalance of crucial cytotoxic/angiogenic
and immunotrophic pathways.
In summary, the ratios of IL-15/Fn14 and IL-18/TWEAK
as quantified by real-time polymerase chain reaction
should be evaluated prospectively as ‘functional’ biomark-
ers of uterine receptivity to document the mechanisms
associated with implantation failures.
4. IL-18/IL-15/TWEAK documentation and
personalized strategies to enhance implantation
4.1. Patients with low endometrial angiogenesis and
IL-18/TWEAK and IL-15 depletion
In patients showing strong IL-18/TWEAK and IL-15
depletion with an absence of vascularisation, implantation
failure could be related to the inability of the endometrium
to react to the embryo at the time of apposition and
adhesion. Hormonal administration as a consequence of
ovarian hyperstimulationwill increase the cytokine deple-
tion, since endometrial exposure to a high concentration
of oestrogens significantly decreases endometrial IL-18
expression (Ledee et al., 2006). A negative impact of oestro-
genson IL-18expressionhasbeenalso reported inmiceand
pigs (Ashworth et al., 2010; Murakami et al., 2005).
In these patients, any strategies leading to the mobi-
lization and activation of endometrial immune cells may
be useful. Minimal hormonal stimulation, exposure to the
male partner’s seminal plasma to enhance immune cell
recruitment, local endometrial injury local endometrial
injury in the mild-luteal cycle preceding the IVF attempt
as well as supplementation with HCG may all improves
the potential for implantation. Studies on seminal plasma
highlight its role in preparing the uterus for implantation
by regulating recruitment and activation of T regulatory
cells (Robertson et al., 2009). Local injury in the mid luteal
phase of the cycle preceding the IVF/ICSI cycle has been
reported to increase pregnancy rates (Almog et al., 2010;
Barash et al., 2003; Narvekar et al., 2010). The underly-
ing rationale is that injury causes induction of immune
cells and pro-inflammatory cytokines in the endometrium
(Gnainsky et al., 2010). The first known human embryo-
derived signal, the human chorionic gonadotropin (HCG)
profoundly influences immunological tolerance and angio-
genesis at thematernal–fetal interface (Perrier d’Hauterive
et al., 2007). HCG intervenes in the development of local
immune tolerance through apoptosis via Fas/Fas-Ligand.
It modulates the Th1/Th2 balance and acts on comple-
ment C3 and C4A/B factors influencing decidual immune
function. The transient immune tolerance evident during
gestation is at least partially achieved via the presence
of regulatory T cells which are attracted by HCG into the
fetal–maternal interface. HCG treatment of activated den-
dritic cells results in an up-regulation of MHC class II, IL-10
and indolamine 2,3 dioxygenase (IDO) expression, reduc-
ing their ability to stimulate T cell proliferation (Berndt
et al., 2009; Tsampalas et al., 2010). Successful implan-
tation also requires extensive endometrial angiogenesis
in the implantation site. Recent data demonstrated pos-
itive angiogenic effects of HCG via its interaction with
endometrial epithelial and endothelial LH/HCG receptors.
Particularly, HCG induces VEGF production by endome-
trial epithelium, increases endothelial cell proliferation
and migration of smooth muscle cells leading to the
maturation of vessels, an important step for placenta-
tion (Berndt et al., 2006). HCG is also involved in the
mobilisation of uNK cells via mannose receptor binding
(Kane et al., 2009).
4.2. Patients with excessive recruitment of activated uNK
cells
In contrast, if patients show excessive recruitment
of activated uNK cells, control of the pro-inflammatory
environment is essential before embryo transfer. In such
conditions, ovarian hyperstimulation as well as a strong
supplementation with progesterone (for its immunosup-
pressive properties) in the mid luteal phase may be useful
(Szekeres-Bartho, 2009; Szekeres-Bartho et al., 2009). The
place of corticosteroids in such strategies is not clear,
with conflicting data on actions in uNK cells. While some
authors observed a decrease of uNK cells following cor-
ticosteroid administration, others authors reported the
opposite. Perez et al. (2005) observed that hydrocorti-
sone is able to enhance the recruitment of CD56 bright
cells through IL-15. Corticoids were also found to promote
uNK cell differentiation from CD34+ stem cells intomature
CD56+ cells (Vitale et al., 2008). Drugs that inhibit the com-
plement pathway, such as heparins as well inhibitors of
ocytocin (Moraloglu et al., 2010), need to be evaluated in
this context.
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To conclude, documentation of the localmobilization of
uNK cells as well as their state of activation may be cru-
cial to clinical care. Some patients with a history of embryo
implantation failure show an IL-18/IL-15/uNK cell deple-
tion and may fail at the step of embryo apposition because
their endometrium is not able to adequately react to sup-
port embryo adhesion. Conversely, some other patients
with the same history of implantation failure show an
excessive uNK cell activation that would lead to failure of
the invasion step through excessive cytotoxicity. Random-
ized cohort studies are now needed to demonstrate that
these diagnostic tools will help the clinician in their daily
practice, and such trials aremandatory in order to progress.
5. A pre-conception dialogue: follicular G-CSF as a
pre-ovulatory biomarker of oocyte competence
Using a microbead-based multiplex sandwich
immunoassay (Luminex Technology), we measured
simultaneously 27 cytokines and chemokines in each
follicular fluid collected from 132 individual follicles
of oocytes subsequently fertilized and transferred after
conventional ovarian hyperstimulation (Ledee et al.,
2008a,b). The originality of the approach was to collect
individual follicular fluids and not pooled follicular fluids
and to ensure traceability of each sample until birth or
failure of the attempt was known. This study showed
that the level of G-CSF in individual follicular fluid sam-
ples correlates with the implantation potential of the
corresponding embryo. The calculation of the area under
the ROC (AUCROC) curve measures the accuracy, i.e. the
ability of a factor to discriminate between two distinct
outcomes. The following thresholds were used to interpret
the AUCROC: 0.9–1: perfect separation; 0.8–0.9: excel-
lent discrimination; 0.7–0.8: acceptable discrimination;
0.6–0.7: poor discrimination; 0.5–0.6: no discrimination.
The AUCROC performance of embryo morphology as a
predictor of implantation ranges between 0.65 and 0.70
for several studies (Guerif et al., 2007). In contrast, for fol-
licular fluid G-CSF the AUCROC distinguishing the embryos
which definitely implanted from those which did not was
0.82 [0.73–0.89] and highly significant (p=0.0001). Sig-
nificant differences in implantation rates were observed
between the embryos with low (<20pg/ml) and high
G-CSF (>24pg/ml) (9% versus 44% respectively, p<0.001).
We subsequently reproduced the data in a cohort of 200
embryos while detailing the adequacy of distinct methods
for measuring follicular fluid G-CSF (Ledee et al., 2010).
Only the multiplex microbead based technology reach the
required sensitivity for adequate quantification.
A third study including 83 women undergoing a mod-
ified natural IVF/ICSI cycle was subsequently conducted
to provide an experimental model allowing complete
traceability, whereby only one oocyte was recovered and
only one embryo subsequently transferred (in contrast
to the multiple embryo transfer which is conventional in
France). Each follicular fluid sample was blindly tested
for 26 soluble factors and each mediator evaluated as a
potential biomarker of subsequent birth. Reproducibility
of follicular composition was evaluated over two modi-
fied natural IVF/ICSI cycles for 15 patients. Follicular fluid
G-CSF was found to be the best predictor of subsequent
birth (AUCROC =0.81, p<0.0001) when using a multivari-
ate logistic regression model (including known covariates
such as age, number of IVF attempts, antral follicle count
and embryo quality). The combination of follicular fluid G-
CSF and morphological embryo scoring on day 2 increased
the AUCROC to 0.86 (p<0.0001). Birth rates per retrieval
were 38% in the group with high G-CSF compared to 5% in
the lowG-CSF group (p<0.0001). Follicular fluid G-CSFwas
significantly correlated over two cycles (r=0.71, p=0.008)
suggesting the possible prognostic value of its documen-
tation before starting any IVF/ICSI attempt (Ledee et al.,
2011). Follicular fluid G-CSF was highly correlated with
cytokines IL-7and IL-17, suggestingkey interactionswithin
the follicle involving immune cells such as dendritic cells
and regulatory T (Treg) cells. Thus, G-CSF in individual
follicular fluids appears to correlate with the birth poten-
tial of the corresponding embryo in two distinct models
of ovarian monitoring, standard ovarian hyperstimulation
andmodified natural IVF/ICSI cycles. This findingmay have
tremendousconsequences for theoverallmorbidity related
to reproductive medicine.
At the level of the reproductive tract, G-CSF has
been previously shown to be secreted by granulosa
cells at ovulation (Salmassi et al., 2004), then within
the endometrium during the luteal phase, and finally
during gestation in the placenta (Duan, 1990). More
recently, a randomized controlled trial reported that G-
CSF administration significantly increases live-birth rates
in patientswith unexplained recurrentmiscarriageswhich
failed to respond to a previous immunotherapy treatment
(Scarpellini and Sbracia, 2009). Almost all the miscarriages
observed in our cohort were found in the group with a low
follicular fluid G-CSF level. Follicular fluid G-CSF may pro-
mote localmaternal–fetal tolerance (Rutella et al., 2005) or
influence the oocyte’s ownmRNA levels or its potential for
self-repair (Yannaki et al., 2005). It might also interactwith
cells in the localmicroenvironment to induce cytokines and
growth factors which are necessary for embryo develop-
ment and implantation.
6. Contribution of the endometrium to the early
cross-talk
Recent studies performed in bovine models were able
to demonstrate that the endometrium shows dramatic
changes in gene expression related to the way the embryo
was produced–by in vivo fertilization, in vitro maturation
or cloning (Bauersachs et al., 2009; Mansouri-Attia et al.,
2009). In addition, Mansouri-Attia et al. raised the hypoth-
esis that the endometrium could be a natural biosensor
for the embryo quality including its potential to develop
to term.
In human, an in vitro confrontation model between
human decidualised stromal cells and blastocyst suggested
the same concept. Decidualised stromal cell gene expres-
sion showed significant variations depending on whether
the blastocyst was still in development or not (Salker et al.,
2010). The result of the study was somewhat surprising,
given the main variation in expression indicated a con-
trol function aiming to stop the process for non-developing
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embryos and suggesting a crucial role of such regulation
especially in patients with early miscarriage (Teklenburg
et al., 2010). These results emphasize the importance
of considering endometrial gene expression during the
pre-fertilization and early pregnancy phases in order to
evaluate whether the recipient tissue will respond to the
embryo adequately.
7. Conclusion
New strategies are emerging to understand the under-
lying pathways leading to implantation failure and to
identify specific defective pathways prior to fertilization
and implantation. In this review, we focus on IL-18, IL-15
and TWEAK in the endometrium as well as G-CSF in the
ovarian follicle. Identification of new biomarkers attest-
ing to oocyte competence or adequate uterine receptivity
should help us to define personalized strategies for infertil-
ity treatment. Such strategies may help to improve oocyte
fertilization, embryo development and selection, uterine
receptivity andultimately endometrial–embryo cross-talk,
an essential process for life.
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